NCT03644420

Brief Summary

Patients with osteoarthritis of the knee undergo visible joint changes in radiology and Magnetic resonance imaging (MRI) tests, but also clinically and histologically. The area of greatest change is at the subchondral/cartilage bone junction. Investigators will determine the association between preoperative clinical evaluation (IKDC and Womac scores), radiological classifications and histopathology. In addition, the role of inflammation in the pathogenesis of osteoarthritis is being given major interest, and inflammation is closely linked with vascularization. It was recently demonstrated that dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) could identify the subchondral bone marrow vascularization changes occurring in osteoarthritis in animals. These changes appeared before cartilage lesions were visible and were correlated with osteoarthritis severity. Thus the opportunity to obtain an objective assessment of bone vascularization in non-invasive conditions in humans might help better understanding osteoarthritis pathophysiology and finding new biomarkers. Investigators hypothesized that, as in animals, DCE-MRI has the ability to identify subchondral bone marrow vascularization changes in human osteoarthritis.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2013

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2013

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2016

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

July 25, 2018

Completed
29 days until next milestone

First Posted

Study publicly available on registry

August 23, 2018

Completed
Last Updated

August 23, 2018

Status Verified

August 1, 2018

Enrollment Period

2.9 years

First QC Date

July 25, 2018

Last Update Submit

August 21, 2018

Conditions

Keywords

OsteoarthritisKneeBoneBone MarrowMagnetic Resonance Imaging

Outcome Measures

Primary Outcomes (8)

  • Score IKDC (International Knee Documentation Committee) for functional evaluation of the articulation

    The IKDC Questionnaire is a subjective scale that provides patients with an overall function score. The questionnaire looks at 3 categories: symptoms, sports activity, and knee function. The symptoms subscale helps to evaluate things such as pain, stiffness, swelling and giving-way of the knee. Meanwhile, the sports activity subscale focuses on functions like going up and down the stairs, rising from a chair, squatting and jumping. The knee function subscale asks patients one simple question: how is their knee at present versus how was their knee prior to injury? Scores are obtained by summing the individual items, then transforming the crude total to a scaled number that ranges from 0 to 100. This final number is interpreted as a measure of function with higher scores representing higher levels of function.

    At inclusion

  • Score WOMAC (Western Ontario McMaster University ) for functional evaluation of the articulation

    An arthritic pain scoring system ranging from 0-no pain/disability to 100-most severe pain/disability

    At inclusion

  • Radiographic assesment of osteoarthritis according to absence/presence of pathology

    At inclusion

  • Assesment of subchondral bone marrow vascularization by dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) according to the % Area Under the Curve (AUC) of perfusion value

    At inclusion

  • The magnetic resonance imaging -based Whole-Organ Magnetic Resonance Imaging (WORMS) Score to assess the full spectrum of knee structures and the severity of knee pathologies

    WORMS scoring for cartilage. Cartilage lesions are scored with the WORMS system on an eight-point scale, as follows: 0 indicates normal cartilage; 1, increased signal with fluid-sensitive intermediate-weighted sequences; 2, partial-thickness defect less than 1 cm in greatest width; 2.5, full-thickness defect less than 1 cm in greatest width; 3, multiple areas of partial-thickness (grade 2) defects intermixed with areas of normal thickness or a partial-thickness defect wider than 1 cm but less than 75% of the region; 4, diffuse (≥75% of the region) partial-thickness loss; 5, multiple areas of full-thickness loss (grade 2.5) or a full-thickness defect wider than 1 cm but less than 75% of the region; and 6, diffuse (≥75% of the region) full-thickness loss.

    At inclusion

  • Analysis of the surgical section by the OARSI score (Osteoarthritis research society international) for evaluation of histologic status

    The OARSI system is based on histologic features of osteoarthritis progression. The system employs analysis of a standard block/section assessment by grade, stage of arthritis with subsequent calculation of an arthritis score. With normal cartilage as grade 0, osteoarthritis severity is divided into six grades. Grades 1-4 involve articular cartilage changes only, whereas grades 5 and 6 involve subchondral bone as well.

    through study completion, an average of 3 years

  • Osteoarthritis pathology assessment according to the number of vessels in the subchondral bone

    Analysis of the surgical section

    through study completion, an average of 3 years

  • Osteoarthritis pathology assessment according to the thickness of the subchondral bone

    Analysis of the surgical section

    through study completion, an average of 3 years

Study Arms (1)

Knee osteoarthritis

Patients with knee osteoarthritis, classified Kellgren-Lawrence 3 or 4, with asymmetric femorotibial joint space narrowing that will follow a surgery for a prosthetic replacement of the knee wil follow the following interventions: * Clinical evaluation * Radiographic assessment of osteoarthritis * Magnetic resonance imaging (MRI) * Histological evaluation of the surgical piece

Diagnostic Test: Clinical evaluationDiagnostic Test: RadiologyDiagnostic Test: Dynamic contrast-enhanced magnetic resonance imagingDiagnostic Test: Evaluation of histological status

Interventions

Clinical evaluationDIAGNOSTIC_TEST

Functional scores for the pathological joint will be determined

Knee osteoarthritis
RadiologyDIAGNOSTIC_TEST
Knee osteoarthritis

Patients will be examined using a 3T MR scanner (MR 750W, General Electrics, Milwaukee, WI) with a dedicated knee coil. Subchondral bone marrow vascularization in medial and lateral femorotibial compartments will be assessed with DCE-MRI and lesions will be graded on MR images.

Knee osteoarthritis

Upper tibial resection pieces will be collected and the vascularization will be determined according to the OARSI score

Knee osteoarthritis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with knee osteoarthritis, classified Kellgren-Lawrence 3 or 4, with asymmetric femorotibial joint space narrowing, that need a knee prosthesis

You may qualify if:

  • Patients with knee osteoarthritis, classified Kellgren-Lawrence 3 or 4, with asymmetric femorotibial joint space narrowing
  • Patients requiring a total knee prosthesis

You may not qualify if:

  • Patients with a known progressive inflammatory pathology (rheumatoid arthritis,...).
  • Patients with previous surgery of the knee
  • Contra-indication for magnetic resonance imaging, chronic renal failure (creatinine clearance \< 30 ml/min), contrast media allergy, orthopaedic hardware around the knee. Patients in whom motion artifacts impaired image analysis will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Biospecimen

Retention: SAMPLES WITHOUT DNA

Upper tibial resection pieces usually removed from patients operated for a total knee prosthesis will be collected.

MeSH Terms

Conditions

Osteoarthritis, KneeOsteoarthritis

Interventions

Physical ExaminationDiagnostic ImagingDynamic Contrast Enhanced Magnetic Resonance Imaging

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

Diagnostic Techniques and ProceduresDiagnosisMagnetic Resonance ImagingTomography

Study Officials

  • Raphael Coursier, MD

    Groupement des Hôpitaux de l'Institut Catholique de Lille

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 25, 2018

First Posted

August 23, 2018

Study Start

May 1, 2013

Primary Completion

April 1, 2016

Study Completion

December 1, 2016

Last Updated

August 23, 2018

Record last verified: 2018-08